Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ImmunoPrecise Antibodies Ltd. - Common Stock (NQ:IPA)

0.4650 +0.0150 (+3.33%)
Streaming Delayed Price Updated: 1:56 PM EDT, Apr 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 443,513
Open 0.4500
Bid (Size) 0.4649 (3)
Ask (Size) 0.4693 (21)
Prev. Close 0.4500
Today's Range 0.4401 - 0.4744
52wk Range 0.2700 - 1.390
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Wondering what's happening in today's after-hours session?
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill

Performance

YTD
+3.3%
+3.3%
1 Month
+18.6%
+18.6%
3 Month
-13.9%
-13.9%
6 Month
-19.2%
-19.2%
1 Year
-66.1%
-66.1%

More News

Read More
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
A Look Ahead: ImmunoPrecise Antibodies's Earnings Forecast
Via Benzinga
Earnings Scheduled For March 28, 2025
Via Benzinga
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
What's going on in today's after hours session
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
What's Going On With ImmunoPrecise Stock Thursday?
Via Benzinga
ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
These stocks are moving in today's pre-market session
Via Chartmill
IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies Announces Key Leadership Changes
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance Period
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
What's Going On With ImmunoPrecise Antibodies Stock Wednesday?
Via Benzinga
Trump’s “Stargate AI” Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
Via AB Newswire
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
Via Benzinga
Exposures Fossil Fuels
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings
Via Benzinga
US Stocks Higher; Netflix Profit Beats Estimates
Via Benzinga
IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation
From ImmunoPrecise Antibodies Ltd.
Via Business Wire

Frequently Asked Questions

Is ImmunoPrecise Antibodies Ltd. - Common Stock publicly traded?
Yes, ImmunoPrecise Antibodies Ltd. - Common Stock is publicly traded.
What exchange does ImmunoPrecise Antibodies Ltd. - Common Stock trade on?
ImmunoPrecise Antibodies Ltd. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ImmunoPrecise Antibodies Ltd. - Common Stock?
The ticker symbol for ImmunoPrecise Antibodies Ltd. - Common Stock is IPA on the Nasdaq Stock Market
What is the current price of ImmunoPrecise Antibodies Ltd. - Common Stock?
The current price of ImmunoPrecise Antibodies Ltd. - Common Stock is 0.4650
When was ImmunoPrecise Antibodies Ltd. - Common Stock last traded?
The last trade of ImmunoPrecise Antibodies Ltd. - Common Stock was at 04/28/25 01:56 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.